EUVIMEDEUVIMED entdecken
Crossref

In vitro activity of ceftazidime-avibactam/aztreonam combination against MBL-producing Pseudomonas aeruginosa strains

Niklas Klein, Jonathan Jantsch, Michaela Simon, Jürgen Rödel, Sören L Becker, Annerose Serr, Joerg Steinmann, Stefan F Ehrentraut, Ernst Mollitor, Gunnar T R Hischebeth

Infection · 2025

DOI: 10.1007/s15010-024-02425-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, 2025. Verfasst von Niklas Klein und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Hospital Hygiene, Bundeswehr Central Hospital Koblenz, 56070, Koblenz, Germany. niklasklein@bundeswehr.org. Hauptthemen laut MEDLINE: Ceftazidime, Pseudomonas aeruginosa, Azabicyclo Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimePseudomonas aeruginosaAzabicyclo CompoundsAnti-Bacterial AgentsAztreonambeta-LactamasesHumansMicrobial Sensitivity TestsDrug CombinationsPseudomonas InfectionsDrug Resistance, Multiple, BacterialBacterial ProteinsDrug Synergism

Stichwörter der Autor:innen

Multi drug resistancePseudomonas aeruginosaAvibactamAztreonamCeftazidimeMBL

Substanzen

CeftazidimeAzabicyclo Compoundsavibactam, ceftazidime drug combinationAnti-Bacterial AgentsDrug CombinationsAztreonambeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Hospital Hygiene, Bundeswehr Central Hospital Koblenz, 56070, Koblenz, Germany. niklasklein@bundeswehr.org.
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, 93053, Regensburg, Germany.
  • Institute for Medical Microbiology, Immunology, and Hygiene, University Hospital Cologne and Faculty of Medicine, University of Cologne, 50937, Cologne, Germany.
  • Institute of Medical Microbiology, Jena University Hospital, 07743, Jena, Germany.
  • Institute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
  • Helmholtz Institute for Pharmaceutical Research Saarland, 66123, Saarbrücken, Germany.

Zitieren

APA

Klein, N., Jantsch, J., Simon, M., Rödel, J., Becker, S. L., Serr, A., Steinmann, J., Ehrentraut, S. F., Mollitor, E., & Hischebeth, G. T. R. (2025). In vitro activity of ceftazidime-avibactam/aztreonam combination against MBL-producing Pseudomonas aeruginosa strains. Infection. https://doi.org/10.1007/s15010-024-02425-4

Vancouver

Klein N, Jantsch J, Simon M, Rödel J, Becker SL, Serr A, et al. In vitro activity of ceftazidime-avibactam/aztreonam combination against MBL-producing Pseudomonas aeruginosa strains. Infection. 2025. doi:10.1007/s15010-024-02425-4

BibTeX
@article{Klein2025,
  author = {Klein, Niklas and Jantsch, Jonathan and Simon, Michaela and Rödel, Jürgen and Becker, Sören L and Serr, Annerose and Steinmann, Joerg and Ehrentraut, Stefan F and Mollitor, Ernst and Hischebeth, Gunnar T R},
  title = {In vitro activity of ceftazidime-avibactam/aztreonam combination against MBL-producing Pseudomonas aeruginosa strains},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02425-4}
}
Kostenlos starten →